Clinical trials
Terminated Obesity trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
411 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 2 |
| 2002 | 3 |
| 2004 | 4 |
| 2005 | 14 |
| 2006 | 23 |
| 2007 | 29 |
| 2008 | 20 |
| 2009 | 23 |
| 2010 | 14 |
| 2011 | 19 |
| 2012 | 22 |
| 2013 | 18 |
| 2014 | 14 |
| 2015 | 21 |
| 2016 | 29 |
| 2017 | 24 |
| 2018 | 23 |
| 2019 | 37 |
| 2020 | 10 |
| 2021 | 14 |
| 2022 | 14 |
| 2023 | 12 |
| 2024 | 9 |
| 2025 | 6 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 411 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sanofi | 10 |
| Pfizer | 9 |
| Mayo Clinic | 7 |
| The Cleveland Clinic | 6 |
| Yale University | 6 |
| Johns Hopkins University | 5 |
| Columbia University | 4 |
| Duke University | 4 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 4 |
| Maastricht University Medical Center | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 411 |
| Overweight | 70 |
| Diabetes Mellitus, Type 2 | 46 |
| Weight Loss | 37 |
| Diabetes Mellitus | 35 |
| Insulin Resistance | 30 |
| Metabolic Syndrome | 21 |
| Hypertension | 20 |
| Obesity, Morbid | 13 |
| Cardiovascular Diseases | 11 |
Trials
Showing 51 to 75 of 411. Each trial links to its page on Pharma Observatory.
311 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.